Show simple item record

Authordc.contributor.authorAlvarez, Carolina 
Authordc.contributor.authorAravena, Andrés 
Authordc.contributor.authorTapia, Teresa 
Authordc.contributor.authorRozenblum, Ester 
Authordc.contributor.authorSolís, Luisa 
Authordc.contributor.authorCorvalán, Alejandro 
Authordc.contributor.authorCamus, Mauricio 
Authordc.contributor.authorAcevedo Alvarez, Manuel 
Authordc.contributor.authorMunroe, David 
Authordc.contributor.authorMaass Sepúlveda, Alejandro 
Authordc.contributor.authorCarvallo, Pilar 
Admission datedc.date.accessioned2019-03-18T11:54:18Z
Available datedc.date.available2019-03-18T11:54:18Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationBMC Cancer, Volumen 16, Issue 1, 2018,
Identifierdc.identifier.issn14712407
Identifierdc.identifier.other10.1186/s12885-016-2261-x
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/166793
Abstractdc.description.abstract© 2016 Alvarez et al.Background: Array CGH analysis of breast tumors has contributed to the identification of different genomic profiles in these tumors. Loss of DNA repair by BRCA1 functional deficiency in breast cancer has been proposed as a relevant contribution to breast cancer progression for tumors with no germline mutation. Identifying the genomic alterations taking place in BRCA1 not expressing tumors will lead us to a better understanding of the cellular functions affected in this heterogeneous disease. Moreover, specific genomic alterations may contribute to the identification of potential therapeutic targets and offer a more personalized treatment to breast cancer patients. Methods: Forty seven tumors from hereditary breast cancer cases, previously analyzed for BRCA1 expression, and screened for germline BRCA1 and 2 mutations, were analyzed by Array based Comparative Genomic Hybridization (aCGH) using Agilent 4x44K arrays. Overall survival was established for tumors in diffe
Lenguagedc.language.isoen
Publisherdc.publisherBioMed Central Ltd.
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceBMC Cancer
Keywordsdc.subjectArray CGH
Keywordsdc.subjectBRCAX
Keywordsdc.subjectBreast cancer
Keywordsdc.subjectGenomic gains
Keywordsdc.subjectGenomic losses
Keywordsdc.subjectOncogenes
Keywordsdc.subjectTumor suppressor
Títulodc.titleDifferent Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile